Applications are being accepted for the fall 2025 class of Redwood SEED Scholars, an inclusive program at UC Davis for individuals with intellectual disabilities.
A new technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses. They also can mop up inflammatory molecules without lowering the entire body’s immune shields.
A newly developed “molecular GPS” to guide immune cells into the brain and kill tumors without harming healthy tissue is the first living cell therapy that can navigate through the body to a specific organ.
UC Davis Health’s Stem Cell Program received a grant from Health Net to improve cancer patients’ access to life-saving CAR-T therapies and clinical trials.
UCSF scientists are uncovering the brain mechanisms behind resilience to stress and exploring new, non-invasive treatments for depression through groundbreaking research in mice.
IN THE NEWS: Around the holidays, the kitchen becomes a busy center of activity. It’s also the location of a number of accidents that cause burns every year. UCI Health trauma surgeon Dr. Syed F. Saquib, who is the director of the UCI Health Regional Burn Center, recently partnered with…
IN THE NEWS: Since the U.S. Food and Drug Administration approved the first GLP-1 drug for use in adolescents 12 and older, more than 30,000 of them have been prescribed the medications. Although the age group makes up just 1% of those prescribed the drugs, UCI Health pediatrician Dr. Dan…
IN THE NEWS: As the cofounder of the ophthalmic branch of Women for World Health, UCI Health ophthalmologist Dr. Sameh Mosaed travels to developing countries to perform eyesight-saving cataract and glaucoma surgeries. Mosaed recently shared with Medscape how the missions have impacted her. “For each person, if you reverse their…
When epidemiologist Kristen Aiemjoy’s son was infected with the very disease she studies, her family experienced the same fear she’s trying to prevent for others.
Health Media Contacts
Find the best contact for health-related media inquiries.
